Registration of the Study of Reyanning Mixture
A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial of the Efficacy and Safety of Treating Acute Tonsillitis With Reyanning Mixture Alone/in Combination With Antibiotics.
Sponsor: Beijing Chao Yang Hospital
A PHASE4 clinical study on Acute Tonsillitis, this trial is ongoing. The trial is conducted by Beijing Chao Yang Hospital and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Not Yet Recruiting → Unknown Status
-
Nov 2018 — Nov 2020 [monthly]
Not Yet Recruiting PHASE4
First recorded
Oct 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing Chao Yang Hospital
- Beijing First Hospital of integrated Chinese and Western Medicine
- China Academy of Chinese Medical Sciences
- The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
- Wangjing Hospital, China Academy of Chinese Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.